Rep. David Taylor Sells $15k–$50k in Lam Research Stock as Shares Drop 3.4%
Representative David Taylor sold $15,001–$50,000 of Lam Research stock on January 8, disclosing the trade on January 21 after which shares fell 3.4%. On October 22, Lam Research reported $1.26 EPS beating estimates by $0.04 with revenue of $5.32 billion up 27.7% year-over-year, and analysts raised targets to $250.
1. Strong Buy Upgrade Signals Elevated Confidence
Analysts have elevated the company to the top tier of their proprietary ranking system, reflecting growing optimism about its earnings trajectory. This upgrade marks the company’s first appearance at the highest rank in over two years and comes as industry demand for advanced wafer fabrication equipment accelerates. Since the inception of this ranking system in 1988, constituents at the top rank have delivered average annualized gains exceeding 23%, underscoring the significance of this endorsement for long-term investors.
2. Q2 Earnings Set to Outpace Street Estimates
For the quarter ended December 2025, the firm is projected to deliver revenue growth approaching 28% year-over-year, driven by surging orders for AI-specialty modules and expanded spending in memory production. Consensus forecasts anticipate an earnings surprise in excess of four cents per share relative to analyst estimates, marking the fifth consecutive beat. Customer inventories remain lean, suggesting further upside to guidance when results are reported in late February.
3. Margin Expansion and Institutional Backing Bolster Outlook
In Q3 fiscal 2025 the company reported a return on equity north of 60% and a net margin near 30%, both record highs supported by operational leverage and pricing discipline. Dividend distributions account for under 25% of net income, leaving ample room for continued share repurchases. Institutional ownership has climbed to roughly 85% of float, while the proportion of buy-side firms assigning a positive recommendation has risen to over 75%. Leading research boutiques have lifted their profit forecasts and upwardly revised average target valuations, reinforcing a constructive three- to six-month outlook.